Random42 Scientific Communication is a prominent scientific communication studio and global leader in medical animation and education. Established in 1992, the United Kingdom-based company has garnered a reputation for excellence, boasting over 340 awards for high-quality medical animation and scientific storytelling. Random42 caters to global pharmaceutical and biotechnology companies, offering specialized services in medical animation and education, virtual reality, augmented and mixed reality, as well as interactive and visually engaging solutions.
The company's extensive experience and industry leadership are evident in its collaborations with a wide spectrum of clients, ranging from the smallest entities to the Top 25 Pharma companies. Through its innovative and immersive approaches, Random42 has positioned itself as a key player in the industries of Health Care, Medical Devices, VR/AR, and Media.
Although specific details about the last investment and the involved investors are currently unavailable, Random42's track record, expertise, and impressive portfolio make it an intriguing prospect for potential venture capital involvement. With its established presence and continued innovation in the ever-evolving fields of scientific communication and technology, Random42 presents an appealing opportunity for investment and partnership within the global market.
There is no investment information
No recent news or press coverage available for Random42 Scientific Communication.